Akce je garantována Českou onkologickou společností.
Při příležitosti 5. ročníku koference se opět sejdou odborníci na diagnostiku a léčbu nádorů ledvin k výměně nejnovějších poznatků v této oblasti.
Předběžný program
- Thursday, 03 April 2014
19.00 – 22.00 Welcome Reception and Dinner
- Friday, 04 April 2014
9.00 – 9.15 Welcome & Opening Remarks
9.15 – 11.45 Live From Prague: Interactive Panel Discussions on the Current and Future Treatment of Metastatic RCC Key Signalling Pathways and Mechanisms of Resistance The management of patients with newly diagnosed metastatic RCC The treatment of patients who experience progression on first‐line therapy The potential role of novel agents and approaches in mRCC management
11.45 – 12.45 Lunch
12.45 – 13.30 Challenge the Experts: Tumour Board With Active Audience Participation Presentation of a novel case in treatment of mRCC
13.30 – 13.45 Break
13.45 – 15.30 Audience Breakout Sessions Attendees will choose from a number of options to tailor schedules according to their interests Each attendee will have the opportunity to attend 2 breakout sessions Options to include sessions on adverse event management, localized treatment options, rare manifestations of RCC, and sequencing strategies
15.30 – 15.40 Break
15.40 – 16.15 A Global View on the Treatment of mRCC: A Roundtable Discussion Panel discussion highlighting regional differences and similarities in mRCC treatment patterns
16.15 Summary Remarks and Day 1 Conclusion
- Saturday, 05 April 2014
7.30 – 8.45 Regional Roundtable Breakfast Informal discussion of locally relevant topics related to mRCC treatment
8.45 – 9.00 Welcome and Summary of Day 1 Activities
9.00 – 9.50 Jeopardy! CORE‐style: Game Show Review and Knowledge Check
9.50 – 10.30 What Is the Role for Neo‐adjuvant and Adjuvant Therapy in mRCC? Overview of recent data for neo‐adjuvant and adjuvant therapy in mRCC
10.30 – 10.45 Break
10.45 – 11.30 Recent Progress in the Systemic Treatment of Non‐clear Cell mRCC Update on new and emerging data related to the treatment of mRCC
11.30 – 12.30 Real‐world Evidence: What Can Consortium Data Tell Us? Discussion on the importance of real‐world data Results from various global initiatives, including the International mRCC Database Consortium and PREDICT Consortium Updates from the PREDICT Consortium
12.30 – 13:00 Closing Remarks and Summary of Day 2
Pořádající instituce
- Novartis Pharma AG, CH-4002, Basel, Švýcarsko
Kontakt
- MUDr Kateřina Voženílková, katerina.vozenilkova@novartis.com
- Novartis s.r.o., Na Pankráci 1724/129, 140 00, Praha 4, tel:602 213 627
- Přidat do kalendáře: 2014-04-03 00:00:00 2014-04-05 23:59:59 Europe/Prague 5th Annual CORE- Conference of Renal Cancer Experts Při příležitosti 5. ročníku koference se opět sejdou odborníci na diagnostiku a léčbu nádorů ledvin k výměně nejnovějších poznatků v této oblasti. Hilton Prague Hotel, Pobřežní 311/1, Praha 8, 186 00